HT
TXMD icon

HAP Trading’s TherapeuticsMD TXMD Stock Holding History

HAP Trading’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-476
Closed -$39K – 2785
2021
Q4 		$39K Buy
476
+10
+2% +$300 ﹤0.01% 1576
2021
Q3 		$27K Buy
466
+228
+96% +$10.1K ﹤0.01% 1720
2021
Q2 		$20K Buy
+238
New +$14.4K ﹤0.01% 1810
2019
Q3 		– Sell
-350
Closed -$44K – 1392
2019
Q2 		$44K Buy
350
+18
+5% +$3.23K ﹤0.01% 759
2019
Q1 		$19K Buy
332
+10
+3% +$2.65K ﹤0.01% 847
2018
Q4 		$31K Sell
322
-52
-14% -$12.7K ﹤0.01% 817
2018
Q3 		$22K Buy
+374
New +$115K ﹤0.01% 750

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return